Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Glucose facilitates the use of indigo

The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Infidelity produces faster sperms

Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.

Sales Representative, Applied Biosystems

Ny Nordamerikachef hos Calliditas

Andrew Udell har utsetts till ny chef för Calliditas Therapeutics verksamhet i Nordamerika.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Samuel Lagercrantz: Samarbete och samverkan är nyckeln till framgång

Trots att många frågor om covid-19 fortfarande är obesvarade har utvecklingen av läkemedel och vaccin gått otroligt snabbt, skriver Samuel Lagercrantz i en ledare.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

ATMP-expert till Eliceras styrelse

Karin Hoogendoorn har valts in i styrelsen för Elicera Therapeutics.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Studie: AI ger mer exakt bröstcancerdiagnostik

Forskare vid Karolinska institutet har utvecklat en metod för vävnadsanalys som med hjälp av AI kan ge en mer precis diagnos vid bröstcancer. Därmed ökar möjlig...

Bio engineering breakthrough in Denmark

Brand new research makes BioGasol's cellulosic ethanol process even more competitive.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Studie: Så länge klarar sig corona på olika ytor

Klarar sig i timmar i luftburna aerosoler och i flera dagar på olika ytor.

Next generation sequencer in an accessible format

The GS Junior System is a new benchtop-sized next generation sequencing platform.

Kemipris till bättre enzymer och fagdisplay

Kungl. Vetenskapsakademien har beslutat utdela Nobelpriset i kemi 2018 till två amerikaner och en britt.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.